Biocryst Pharmaceuticals reported $13.88M in Trade Creditors for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
DBV Technologies DBVT:US USD 15.37M 972K
Alnylam Pharmaceuticals ALNY:US USD 40.57M 11.85M
Daiichi Sankyo 4568:JP JPY 332.22B 1.94B
Enanta Pharmaceuticals ENTA:US USD 6M 4.76M
Intra Cellular Therapies ITCI:US USD 14.22M 3.47M
IONIS PHARMACEUT IONS:US USD 20.54M 10.19M
Karyopharm Therapeutics KPTI:US USD 813K 881K
Mirati Therapeutics MRTX:US USD 19.45M 4.82M
Novavax NVAX:US USD 145M 241.49M
Ptc Therapeutics PTCT:US USD 20.86M 2.02M
Regeneron Pharmaceuticals REGN:US USD 535.6M 1.4M
Sarepta Therapeutics SRPT:US USD 118.46M 62.25M
Ultragenyx Pharmaceutical RARE:US USD 23.53M 10.68M
Vertex Pharmaceuticals VRTX:US USD 126.9M 71.1M
YTE INCY:US USD 163.17M 31.6M